Ameloblastic fibroma

Ameloblastic fibroma (AF) is a rare, benign, biphasic odontogenic neoplasm composed of both neoplastic odontogenic epithelium and neoplastic ectomesenchyme, without formation of dental hard tissues.[1][2] It is classified under mixed epithelial and mesenchymal odontogenic tumors in the WHO Classification of Head and Neck Tumours, retained in both the 4th (2017) and 5th (2022) editions.[3][4] AF characteristically presents in children and adolescents as a well-defined radiolucent jaw lesion, most commonly in the posterior mandible.[1][5] The tumor is unique among odontogenic neoplasms in that both tissue components are considered neoplastic, and it occupies one end of a conceptual spectrum that extends through ameloblastic fibrodentinoma and ameloblastic fibro-odontoma to the odontoma.[1] Whether a subset of lesions in young patients represents a developing odontoma (hamartomatous variant) rather than a true neoplasm remains debated.[5][6] Conservative surgical enucleation is the standard treatment, though the potential for recurrence and rare malignant transformation to ameloblastic fibrosarcoma necessitates long-term follow-up.[6][7]

• Current accepted name: Ameloblastic fibroma (WHO 2017 and 2022 classifications)[3][4]
• Historical classification context: In the 2005 WHO classification, AF was grouped with ameloblastic fibrodentinoma (AFD) and ameloblastic fibro-odontoma (AFO) as a spectrum of mixed odontogenic tumors. The 2017 and 2022 editions retained AF as a distinct benign neoplasm but reclassified AFD and AFO as presumed developing odontomas, a decision that remains controversial.[3][8]
• Obsolete or related terms:
  • "Soft odontoma" — an older synonym no longer in standard use
  • Granular cell ameloblastic fibroma and peripheral ameloblastic fibroma are recognized rare histologic and topographic variants[9]
• Malignant counterpart: Ameloblastic fibrosarcoma (AFS), in which the mesenchymal component becomes malignant while the epithelial component remains benign[7][10]

• Frequency: AF accounts for approximately 2% of odontogenic tumors overall. When odontomas are excluded, AF represents roughly 6.5% of central odontogenic tumors.[10][11]
• Age: Predominantly a tumor of children and adolescents, with a mean age at diagnosis of approximately 14.9 years; about 80% of cases are diagnosed before age 22. Occurrence in adults older than 22 years is not uncommon and is more strongly associated with true neoplastic behavior.[5][6]
• Sex: A slight male predilection is reported in most series.[6]
• Anatomic distribution: The posterior mandible (premolar–molar–ramus region) is the most common site, accounting for approximately two-thirds of cases. Maxillary involvement is less frequent.[1][8][12]
• Association with unerupted teeth: Approximately 46% of AF cases in young patients are associated with unerupted teeth.[13]

Presentation

• Most patients present with a painless, slowly progressive swelling of the affected jaw. Approximately 28% of cases are small and asymptomatic, discovered incidentally on routine radiographic examination.[1][5][14]
• The most common chief complaint is a non-erupted or missing tooth in the posterior mandible, prompting radiographic investigation.[15]

Examination findings

• Firm, non-tender bony expansion of the buccal and occasionally lingual cortex[5]
• Overlying mucosa is typically intact and normal in color
• Displacement or absence of teeth in the affected region[14][15]

Tempo and complications

• Growth is slow and expansile rather than infiltrative. Approximately 72% of cases exhibit moderate-to-severe bone expansion at diagnosis.[5][12]
• Pain, paresthesia, and mucosal ulceration are uncommon and, when present, should raise concern for a more aggressive process such as ameloblastic fibrosarcoma.[1]
• Root resorption of adjacent teeth occurs occasionally and may indicate a more aggressive variant.[15]

Location and distribution

AF arises centrally within the jaws, with a strong predilection for the posterior mandible (premolar, molar, and ramus regions).[1][8] Maxillary lesions are less common and may extend into the maxillary sinus.[12] The lesion is typically solitary and centered in the medullary bone.

Periphery and shape

• Well-defined borders: The hallmark is a well-demarcated radiolucency with a corticated or sclerotic margin, imparting a cyst-like appearance.[14][16]
• Shape: Lesions are round to ovoid when small; larger tumors may become lobulated or irregularly contoured.

Locularity

• Unilocular: Small lesions are characteristically unilocular, producing a well-circumscribed radiolucency that closely mimics an odontogenic cyst.[5][16]
• Multilocular: Larger, more expansile tumors may demonstrate a multilocular or septated pattern reminiscent of ameloblastoma. Multilocularity tends to correlate with larger lesion size and neoplastic rather than hamartomatous behavior.[1][5]

Internal architecture

• The internal content is uniformly radiolucent, reflecting the entirely soft-tissue composition of the tumor (no dental hard tissue formation). This absence of internal radiopacity is a key distinguishing feature from ameloblastic fibro-odontoma and developing odontoma, both of which contain variable amounts of calcified material.[1][2][17]
• Rare reports describe faint internal radiopacities, though these could not be confirmed histopathologically as calcified dental structures.[18]

Effects on teeth and adjacent structures

• Tooth displacement: Developing or erupted teeth adjacent to the lesion are commonly displaced, and unerupted teeth may be submerged to the inferior border of the mandible.[14][15]
• Root resorption: Occasionally observed on adjacent erupted teeth; when present, it may suggest more aggressive biologic behavior.[15]
• Tooth impaction: The lesion frequently surrounds or is intimately associated with the crown of an unerupted tooth, mimicking a dentigerous cyst.[13][14]

Cortical involvement and growth pattern

• Cortical expansion: Buccal and lingual cortical expansion is common, particularly in larger lesions, and is appreciable on cross-sectional imaging.[5][14]
• Cortical thinning: Progressive thinning of the expanded cortex occurs with tumor growth; CBCT is more sensitive than panoramic radiography for detecting this finding.[19]
• Cortical perforation: Uncommon in AF and, when present, should prompt consideration of ameloblastic fibrosarcoma or ameloblastoma.[10]
• Growth pattern: Expansile rather than infiltrative; the tumor displaces rather than invades surrounding structures.[12]

Volumetric imaging contributions

Cross-sectional imaging (CBCT) provides superior assessment of cortical integrity, three-dimensional extent, relationship to the inferior alveolar canal, and buccal-lingual expansion compared with panoramic radiography alone.[14][19] These details are essential for surgical planning, particularly in pediatric patients where preservation of developing tooth germs and jaw growth centers is a priority.

Distinguishing radiographic patterns by biologic variant

Small, asymptomatic, unilocular lesions with minimal or no bone expansion in young children are more likely to represent a hamartomatous (developing odontoma) variant, whereas large, expansile, multilocular lesions with extensive bone destruction favor a true neoplasm.[5]

CT and MRI may be employed for large or maxillary lesions where soft-tissue extent, sinus involvement, or skull-base proximity requires evaluation beyond what CBCT provides.[4][12]

• CT: Demonstrates a well-defined, homogeneous, low-attenuation intraosseous mass without internal calcification. Cortical expansion and thinning are well depicted. The absence of internal calcified matrix helps distinguish AF from ameloblastic fibro-odontoma and odontoma.[4]
• MRI: Limited published data exist specifically for AF. By analogy with its soft-tissue composition, the tumor is expected to show intermediate signal on T1-weighted images and high signal on T2-weighted images, reflecting its myxoid ectomesenchymal stroma. MRI is most useful for evaluating soft-tissue extension in maxillary lesions or when cortical perforation is suspected.[4]
• Contrast-enhanced imaging: In ameloblastoma, contrast-enhanced CT and MRI characteristically reveal a mixed cystic-and-solid pattern with enhancing mural nodules. AF, being a solid soft-tissue tumor without the cystic architecture typical of ameloblastoma, would be expected to show more homogeneous enhancement, though systematic data are lacking.[20]

The radiographic differential centers on well-defined radiolucent jaw lesions in children and adolescents, particularly those associated with unerupted teeth in the posterior mandible.

The highest-risk diagnostic pitfall is misidentification of AF as ameloblastoma, because the two share overlapping radiographic and histologic features but require fundamentally different surgical approaches — enucleation for AF versus segmental resection for ameloblastoma.[2][21] Incisional biopsy is essential for definitive diagnosis, and the pathologist must distinguish the immature, dental-papilla-like stroma of AF from the mature fibrous stroma of ameloblastoma.[2]

Diagnostic microscopic features

AF is a biphasic tumor composed of two neoplastic components:[1][9]

• Epithelial component: Branching and anastomosing strands and islands of odontogenic epithelium with a peripheral rim of columnar or cuboidal cells resembling the enamel organ. The stellate reticulum zone is poorly developed compared with ameloblastoma. The epithelial islands are randomly distributed without organization into tooth-germ structures.[1][2]
• Mesenchymal component: Cell-rich, myxoid ectomesenchyme resembling the dental papilla of the developing tooth germ. This immature stroma is the critical distinguishing feature from ameloblastoma, which contains mature fibrous connective tissue.[1][2]
• Absence of hard tissue: No predentin, dentin, enamel matrix, or cementum is formed. Any hard tissue formation reclassifies the lesion as ameloblastic fibrodentinoma or ameloblastic fibro-odontoma.[1][9]
• Mitotic activity: Mitoses are usually frequent in both components but are morphologically normal. Abnormal mitoses, nuclear atypia, and hypercellularity in the stromal component signify transformation to ameloblastic fibrosarcoma.[1][10]

Variants

• Granular cell AF: Rare; mesenchymal cells undergo granular transformation.[9]
• Peripheral AF: Extremely rare extraosseous variant arising in the gingival soft tissues.[9][22]

Molecular findings

• BRAF p.V600E mutation is identified in the mesenchymal component in approximately 68% of AF cases, and in both stromal and epithelial components by immunohistochemistry. This mutation is shared with ameloblastoma and ameloblastic fibrosarcoma but is absent in odontomas, providing a molecular discriminator.[8][21]
• Copy number alterations (CNAs) are detected in the mesenchymal component of approximately 47% of AF cases, contrasting with uniformly normal CNAs in odontomas. CNA profiling may help distinguish true neoplasms from hamartomatous lesions and anticipate disease progression.[8]
• Elevated MIB-1 (Ki-67) labeling indices in the mesenchymal component of recurrent AF and ameloblastic fibrosarcoma, compared with primary AF, may serve as a marker of biologic aggressiveness.[9]

Radiologic-pathologic correlation

The entirely radiolucent imaging appearance corresponds to the exclusively soft-tissue composition without dental hard tissue. The well-corticated border reflects the encapsulated, expansile growth pattern. Multilocular radiographic patterns correlate with larger tumors containing lobulated masses of myxoid stroma separated by fibrous septa.[1][5]

Treatment

• Conservative surgery (enucleation/curettage) is the standard initial treatment, particularly in children and adolescents, to preserve the developing jaws and dentition. Complete excision with thorough curettage of the bony cavity is essential.[2][6][14]
• Radical resection (segmental or marginal) is generally reserved for large, destructive, or recurrent lesions and for tumors in patients older than 22 years, where true neoplastic behavior is more likely. Radical procedures are associated with significantly longer recurrence-free survival.[5][6]
• Patient age is a key factor in treatment selection: radical surgery should not be employed as first-line treatment in young patients given the morbidity to the growing jaw.[6]

Recurrence

• Reported recurrence rates vary by series and treatment method. A comprehensive literature review of 123 cases (predominantly treated conservatively) identified an overall recurrence rate of 33.3%, while a more recent series of 19 cases reported 21.1%. The higher historical figure likely reflects publication bias toward unusual or aggressive cases.[6][8][10]
• Recurrence typically occurs within the first few years after surgery, underscoring the need for close postoperative surveillance.

Malignant transformation

• Transformation to ameloblastic fibrosarcoma is the most clinically significant long-term risk. An overall malignant transformation rate of approximately 11% has been reported among recurrent tumors, with a mean interval of approximately 55 months between initial treatment and sarcomatous change. Approximately 25% of all ameloblastic fibrosarcoma cases arise from a pre-existing or recurrent AF.[6][10]
• Older patient age at initial presentation is significantly associated with malignant transformation risk.[6]

Surveillance

• Long-term clinical and radiographic follow-up is mandatory, with periodic imaging (panoramic radiography or CBCT) to detect early recurrence.[6][14]
• Any recurrence should be re-biopsied to exclude sarcomatous transformation, with particular attention to stromal cellularity, atypia, and mitotic activity.[1][7]

Prognosis

• Overall prognosis is excellent when complete excision is achieved. The tumor is less infiltrative than ameloblastoma and responds well to conservative surgery. Satisfactory bony healing is expected postoperatively.[2][15][21]

Neoplasm versus hamartoma distinction

The biologic nature of AF remains a subject of active investigation. Two clinically relevant variants have been proposed:[5]

• Hamartomatous variant: Small, asymptomatic, unilocular lesions with minimal expansion in young children may represent early-stage developing odontomas. A small number of recurrent AF cases have shown maturation with formation of dental hard tissues, supporting this concept.[6]
• Neoplastic variant: Large, expansile, destructive lesions — and all AF occurring in patients older than 22 years — are considered true neoplasms.[5][6]

Because histopathology alone cannot reliably distinguish these variants, clinical and radiographic features (patient age, lesion size, expansion, locularity) and molecular profiling (BRAF mutation status, CNA analysis) are increasingly used to guide biologic characterization and treatment intensity.[5][8]

Pediatric considerations

AF predominantly affects children during active odontogenesis. Surgical planning must balance the imperative for complete tumor removal against preservation of developing tooth germs, the inferior alveolar nerve, and mandibular growth centers.[1][6] Conservative initial management with close surveillance is preferred, reserving more aggressive intervention for recurrence or features suggesting neoplastic behavior.[6]